Tris(dimethylamino)sulfonium difluorotrimethylsilicate

CAS : 59218-87-0

Ref. 3D-FT58199

Informations sur le produit

• Nom: Tris(dimethylamino)sulfonium difluorotrimethylsilicate
• Synonymes: TASF Reagent, 2,2-difluoro-N,N,1,1,3,3-hexamethyl-2-(trimethylsilyl)-2lambda~6~-diazathian-2-amine, Methanaminium, N-[bis(dimethylamino)-λ⁴-sulfanylidene]-N-methyl-, difluorotrimethylsilicate(1-) (1:1), Silicate(1-), difluorotrimethyl-, S,S-bis(dimethylamino)-N,N-dimethylsulfiliminium, Sulfiliminium, S,S-bis(dimethylamino)-N,N-dimethyl-, difluorotrimethylsilicate(1-), TAS-F reagent, Tris(Dimethylamino)Sulfonium, Tris(dimethylamino)(trimethylsilyl)sulphur, Tris(dimethylamino)sulfonium difluorotrimethylsilicate(1-), Tris(dimethylamino)sulfonium trimethylsilyldifluoride, Tris(dimethylamino)sulfur(1+) difluorotrimethylsilicate(1-), Methanaminium, N-[bis(dimethylamino)-λ4-sulfanylidene]-N-methyl-, difluorotrimethylsilicate(1-) (1:1)

Description

Tris(dimethylamino)sulfonium difluorotrimethylsilicate is a solute that is used in synthetic chemistry. It has been shown to stimulate bone growth in vitro and to inhibit the metastasis of cancer cells in animal studies. Tris(dimethylamino)sulfonium difluorotrimethylsilicate has also been shown to be an effective treatment for bladder cancer. This compound has been shown to bind to cortistatin, an active substance that inhibits the proliferation of human bladder cancer cells. The compound binds to benzyl groups on cortistatin and prevents it from binding with its receptors on the bladder cancer cells, leading to cell death.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 275.48 g/mol
• Formule: C₆H₁₈N₃S•C₃H₉F₂Si
• Degré de pureté: 90%
• Couleur/Forme: Powder